A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular …

TM Roston, W Guo, AD Krahn, R Wang… - Journal of …, 2017 - Elsevier
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion
channelopathy usually caused by gain-of-function mutations ryanodine receptor type-2 …
被引用次数：57 相关文章

A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular …

TM Roston, W Guo, AD Krahn, R Wang… - Journal of …, 2016 - europepmc.org
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion
channelopathy usually caused by gain-of-function mutations ryanodine receptor type-2 …

[引用][C] A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular …

TM Roston, W Guo, AD Krahn, R Wang… - Journal of …, 2017 - cir.nii.ac.jp
A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction
and atypical catecholaminergic polymorphic ventricular tachycardia | CiNii Research CiNii 国立 …

A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular …

TM Roston, W Guo, AD Krahn, R Wang… - Journal of …, 2017 - infona.pl
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion channelopathy
usually caused by gain-of-function mutations ryanodine receptor type-2 (RyR2). Left …

A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular …

TM Roston, W Guo, AD Krahn… - Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion
channelopathy usually caused by gain-of-function mutations ryanodine receptor type-2 …